Background: Although the number of excised LNs has been associated with patient prognosis in many solid tumors, this association has not been widely investigated in cutaneous melanoma. This study aims to evaluate the association between the number of excised regional lymph nodes (LNs) and melanoma-specific survival. Results: The number of excised LNs correlated with younger age (P < 0.001), male sex (P < 0.001), neck LN field (P < 0.001), LN micrometastasis (P < 0.001) and number of positive LNs (P < 0.001).The number of excised LNs was an independent prognostic factor (HR = 0.85; P = 0.002) after adjustment for other staging features. Upon subgroup analysis, the number of excised LNs had a significant prognostic value in patients bearing 1.01-2.00 mm (HR = 0.79; P = 0.032) and 2.01-4.00 mm (HR = 0.71; P < 0.001) thick melanomas, primary tumors showing ulceration (HR = 0.86; P = 0.033) and Clark level V of invasion (HR = 0.86; P = 0.010), LN micrometastasis (HR = 0.83; P = 0.014) and two to three positive LNs (HR = 0.71; P = 0.001). Finally, this study investigated the influence of the number of excised LNs on patient staging: only when ≥11 nodes were excised the AJCC N stage could stratify prognosis (P < 0.001). Considering the number of excised LNs for each lymphatic field, at least 14, 11, 10 and 12 LNs were needed to stage patients according to the AJCC N stage after a lymphadenectomy of the neck, axilla, inguinal and ilioinguinal LN fields, respectively.
introduction
The number of positive lymph nodes (LNs) is one of the main determinants of prognosis in melanoma patients with LN metastasis, along with the LN tumor burden (i.e. micro-or macrometastasis) and the presence of ulceration in the primary tumor [1] . Based on the fact that patients with advanced LN disease are at greater risk of disease progression, randomized trials have investigated whether lymphadenectomy may be effective in patients with clinically negative regional LN [2] . Although these trials were negative [2, 3] , analyses of nonrandomized participants revealed that dissection offered a survival benefit in case of subclinical LN metastasis (i.e. LN metastasis detected with sentinel LN biopsy, SLNB) [3, 4] , leading to the design of the ongoing Multicenter Selective Lymphadenectomy Trial-II (MSLT-II), which is comparing lymphadenectomy and observation in SLNB-positive patients [5] . This trial is expected to answer the question on the therapeutic role of lymphadenectomy carried out for subclinical LN metastasis, but results will take years to be mature for analysis. In the meanwhile, investigating whether the number of excised LNs at lymphadenectomy is associated with patients' outcome can provide useful information for the management of patients with skin melanoma. Studies so far conducted demonstrated the prognostic value of the LN ratio, which is the proportion of positive among examined LNs [6] [7] [8] [9] [10] [11] , supporting, though indirectly, the number of excised LNs as a prognostic factor. However, these findings can be biased by the inclusion of the number of positive LNs, one of the major determinant of melanoma patient prognosis, in the LN ratio [12] . Our objective was to investigate the association between the number of excised LNs and melanoma-specific survival in a large cohort of patients with metastatic regional LNs.
patients and methods
Retrospective data from melanoma patients with LN metastasis who underwent a lymphadenectomy (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) at nine IMI centers were gathered in a multicenter dedicated database.
Data were extracted according to the following selection criteria: (1) LN metastasis from known single primary melanoma; (2) absence of in-transit and distant metastasis at the time of primary melanoma diagnosis and lymphadenectomy; (3) lymphadenectomy of a single regional field (neck, axillary or groin); (4) availability of information regarding tumor thickness, LN tumor burden, number of excised and positive LNs (including SLNB or any other LN biopsy when carried out) and melanoma-specific survival. Patients who had a popliteal, an epitroclear and a pelvic only LN dissection were excluded, as well as patients who underwent a lymphadenectomy for regional LN failure after a previous dissection. Conversely, this series included SLNB-negative patients who have had a regional LN recurrence without distant disease and underwent a lymphadenectomy.
Description of surgery technique, pathology protocol and statistical method is available as online available supplementary material.
results
There were 2507 patients eligible for this study. Clinicopathological features and distribution of the number of excised LNs are reported in Tables 1 and 2, respectively. Upon multivariable regression analysis, later years of diagnosis (difference between median values: three LNs; P < 0.001), younger age (difference between median values: two LNs; P < 0.001), male sex (difference between median values: two LNs, P = 0.004), neck LN field (P < 0.001, Table 2 ), micrometastasis (difference between median values: one LN; P < 0.001) and a greater number of positive LNs (P < 0.001, Table 2 ) were associated with a greater number of excised LNs, while groin LN field (P < 0.001, Table 2 ) correlated with lesser excised LNs (supplementary Table S1 , available at Annals of Oncology online).
At a median follow-up of 54 months [interquartile range (IQR) 21-98], 623 patients (25%) died for melanoma. The number of excised LNs was an independent predictor of melanoma-specific survival after adjustment in a multivariable model which encompassed also later year of diagnosis, older age, male sex, primary tumor showing greater thickness, ulceration and Clark level V, as well as AJCC sub-stages N2 and N3 ( In order to prove that the number of excised LNs influences tumor staging, we searched for a cutoff value that identifies a number of excised LNs that may be required for staging patients with LN metastasis. The role of the number of excised LNs in providing better tumor staging is visualized in Figure 1 : patients with ≤10 excised nodes (N = 208, 8.3%) were not adequately staged as showed by the crossing survival curves of the AJCC N-stage 1, 2 and 3 (test for trend, P = 0.406; Figure 1A ). This lack of prognostic stratification was maintained at multivariable Figure 1B ). This prognostic significance was maintained at multivariable analysis after adjusting for the other considered variables (AJCC N2 versus N1, HR = 1.26; 95% CI 1.02-1.56, P = 0.034; AJCC N3 versus N1, HR = 1.67; 95% CI 1.33-2.11, P < 0.001).
We searched for cutoff values for neck, axillary, inguinal and ilioinguinal LN fields (supplementary Figure S1 , available at LNs were excised in the neck (P = 0.309), axilla (P = 0.957), inguinal (P = 0.880) and ilioinguinal (P = 0.404) lymphatic fields, respectively, the AJCC N substages did not have prognostic value. Strikingly, the AJCC N substage stratified patient survival when at least 14, 11, 10 and 12 LNs were excised in the neck (P = 0.05), axilla (P < 0.001), inguinal (P = 0.027) and ilioinguinal (P < 0.001) lymphatic fields, respectively. Finally, we compared the prognostic value of inguinal and ilioinguinal lymphadenectomy. Multivariable analysis did not identify differences between patients who underwent these two dissections (HR 0.86; 95% CI 0.751-1.404; P = 0.17).
discussion
In this multicentric study, patients who had a higher number of excised LNs after lymphadenectomy showed a better prognosis, independently of clinical features and tumor stage.
Previous studies reported an association between the number of excised LNs and survival in patients with clinically positive LNs [13, 14] . Our study adds meaningful information to these reports as it analyzes the highest number of patients ever enrolled for this purpose and included not only patients undergoing therapeutic LN dissection for clinically evident disease but also those undergoing completion LN dissection for a microscopic node metastasis detected with the SLNB technique.
Other studies have investigated the number of excised LNs relative to the number of positive LNs evaluating the so-called LN ratio [6] [7] [8] [9] [10] [11] . Low values of this parameter (e.g. ≤0.1, which corresponds to 1, 2 or 3 positive LNs over ≥10, ≥20 or ≥30 excised LNs, respectively) were associated with better patient outcomes independently of the number positive LNs, leading to corroborate, though indirectly, the prognostic relevance of the number of excised LNs.
There are at least three possible explanations that might underlie the association between patient prognosis and the number of excised LNs: the prognostic value of the number of excised LNs, the therapeutic value of a thorough dissection and the immunological role of the LNs.
LN dissection has a pivotal staging role in melanoma as well as in virtually all solid tumors [15] [16] [17] . A thorough dissection allows for the removal and identification of all metastatic LNs, the number of positive LNs being one of the most important parameters of the AJCC N-stage [18] . The association we found between number of excised LNs and prognosis might be related to the better staging obtained in patients with a greater number of excised LNs at lymphadenectomy. For instance, a patient classified as AJCC N1 substage after a thorough lymphadenectomy is more likely to actually bearing only one metastatic LN when compared with a patient who underwent a more limited LN dissection, as demonstrated by the correlation between numbers of LNs removed and positive (Table 3) . Furthermore, we observed a lower risk of death in the later study period when more LNs were excised (supplementary Table S1 , available at Annals of Oncology online), supporting the principle of more accurate staging with more complete surgery.
In this regard, another finding of our study could be of particular interest, as we demonstrated that the AJCC N substages stratified survival of patients when at least 11 LNs were excised ( Figure 1A and B) . In order to provide minimum number of excised LNs for each nodal field, we identify that at least 14, 11, 10 and 12 LNs are required to stage patients after neck, axillary, inguinal and ilioinguinal dissection, respectively, according to the AJCC N substages (supplementary Figure S1 , available at Annals of Oncology online).
Another attempt to define adequacy of lymphadenectomy based on the number of excised LNs was reported by Spillane et al., who identified minimum numbers of LNs to be excised according to the dissected anatomical boundaries within each nodal field, without accounting for patient survival [10, 19] . Ninety percent of patients had 10, 6, 20, 8 and 14 excised LNs after axillary dissection, neck dissection involving ≤3 or ≥4 anatomical levels, inguinal and ilioinguinal lymphadenectomy, respectively. Differently, our study analyzed melanoma-specific survival and identified a LN count that allows patient risk stratification according to the AJCC system. Despite the differences in the methodological approaches used in our study and in those from Spillane et al., their cutoff values for axillary, inguinal and ilioinguinal dissection are similar to those we identified. The relatively small number of patients who had a neck dissection in our study did not allow to group them according to the dissected neck anatomic levels, preventing a comparison with the results of Spillane et al. for this LN field. These results have implication for monitoring quality assurance of lymphadenectomy, given the general agreement about the use of the number of excised LNs as a measure to assess quality of surgery [12, 19, 20] . Showing that patients who had a higher number of excised LNs had also a better prognosis, this study lends support also to the alternative hypothesis that a thorough dissection might have a therapeutic effect. However, the design of this study cannot directly answer to the question of whether or not lymphadenectomy prolongs survival in patients with LN metastasis from melanoma, an issue that can be formally addressed only by a randomized trial. The randomized studies so far conducted in patients with clinically negative LNs at primary melanoma diagnosis have not demonstrated an impact on overall survival for immediate lymphadenectomy when compared with therapeutic lymphadenectomy carried out in patients with clinically evident disease [2, 3] . Evidence from the subgroup of patients with LN metastasis revealed better overall survival rates for those who underwent a completion dissection for a positive SLNB, particularly with intermediate thickness primary tumor [3, 4] . Intriguingly, results of subgroup analysis in our study lead to similar conclusions. In fact, the number of excised LNs was a prognostic factor in patients with intermediate thickness melanoma (but not in those bearing a thin or thick primary tumor) and in patients with LN micrometastasis but not in patients with macrometastasis. The observation that the prognostic value of the number of excised LNs seems limited to LN micrometastasis underlines the importance of considering timing of lymphadenectomy (early versus delayed) and LN tumor burden (micro versus macrometastasis) for accurate patient staging [21] .
Finally, naturally occurring variability in number of LNs across individuals may theoretically have influenced the results of this study. Should this be the case, the findings of this study would lead to hypothesize that patients with a higher number of LNs in the regional field might have a better prognosis, putatively because of a more effective immune response.
This study might be limited by the lack of data regarding possible confounding factors, such as the body mass index, which theoretically may affect the number of LNs in a given nodal field and adjuvant therapies, such as interferon alpha [22] and radiotherapy [23] , which influence patient outcomes.
In conclusion, this study demonstrated that the number of excised LNs at lymphadenectomy is significantly and independently associated with melanoma-specific survival and that a minimum number of LNs is required for the correct staging of patients. Further research is required to validate the prognostic effectiveness of minimum number of LNs to be excised at lymphadenectomy for melanoma. 
